A preliminary study on the treatment of epithelial simplex virus keratitis based on confocal microscopy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064658

Enrollment

Unknown

Registered

2022-10-13

Start date

2022-10-20

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epithelial herpes simplex keratitis

Interventions

Observation group:Conventional treatment plus 0.05% cyclosporine eye drops

Control group:Conventional therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 25-60 years old, Epithelial herpes simplex keratitis (dendritic keratitis, map keratitis).

Exclusion criteria

Exclusion criteria: 1. Patients with other ocular inflammatory diseases, ocular hypertension and systemic diseases such as diabetes and immune diseases were excluded.

Design outcomes

Primary

Measure	Time frame
Symptom;Healing time;Degree of corneal edema;Vision;	—

Countries

China

Contacts

Public ContactXu Man

Wuhan Aier Eye Hospital

15827062369@163.com+86 15827062369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026